VNDA (Vanda) Net earnings per share growth this year

Corporate emblem and logo of Vanda (VNDA)

Cost optimization through the outsourcing of production and logistics serves as a key driver for Vanda Pharmaceuticals (VNDA). The annual change in EPS visualizes this effect, where 33.10 shows the current value of the metric. Stability is supported by the brand's high authority in neuropsychiatry and a mature portfolio of insomnia treatments protected by strict patent rights.

VNDA (Vanda Pharmaceuticals) Earnings per share growth in current year history from 07/04/2022 to 11/15/2026

Financial and market metric breakdowns for vandapharma.com (VNDA)

- stock value and consensus price forecast:
Market Price Vanda Pharmaceuticals Inc|VNDA - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation Vanda Pharmaceuticals|VNDA - Enterprise Value
- company book value details:
Accounting Value of a Share Vanda Pharmaceuticals|VNDA - Company Book Value|Market-to-Book Ratio vandapharma.com|VNDA - Cumulative Company Assets
- debt burden and liquidity indicators:
Debt to Equity Vanda Pharmaceuticals|VNDA - Long-Term Debt to Capital|Short-Term Debt to Capital Vanda Pharma|VNDA - Company Debts|Debt to Book Value Ratio Vanda Pharmaceuticals|VNDA - Company Long-Term Debts|Company Short-Term Indebtedness Vanda Pharmaceuticals|Quick Ratio vandapharma.com
- net income and valuation multiples indicators:
VNDA - Net Income|Expected Net Income Vanda Pharmaceuticals|VNDA - Price to Earnings Ratio|Price to Expected Earnings Ratio Vanda Pharmaceuticals|VNDA - PEG Multiple|Business Value to Operating Income Before Depreciation Vanda Pharmaceuticals|VNDA - Operating profit EBITDA|Net earnings per share (EPS TTM) Vanda Pharmaceuticals|VNDA - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months vandapharma.com|VNDA - Earnings per share growth in current year|Expected earnings per share growth for next year Vanda Pharmaceuticals
- revenue and sales proceeds data:
VNDA - Revenue and Sales Volume|Projected Sales Volume Vanda Pharmaceuticals Inc|VNDA - P/S Multiple|Forward Price-to-Revenue Multiple Vanda Pharmaceuticals
Basic company analysis:Vanda Pharmaceuticals Inc
Finished products of Vanda Pharmaceuticals

For Vanda Pharmaceuticals (VNDA), which specializes in drugs for the therapy of psychiatric disorders, this indicator serves as a measure of the effectiveness of monetizing patented developments. By analyzing the earnings per share growth compared to the previous year on the GURU.Markets platform, an investor assesses the annual dynamics of net income per share, which allows for the timely diagnosis of business stagnation and prevents overpaying for an asset with fading potential.

Direct competitors

Earnings per share growth rate in current year Alkermes Inc. (ALKS)|AVDL (avadel.com) - Earnings growth in current year|Net earnings per share growth this year Atai Life Sciences N.V. (ATAI)|Earnings growth in current year GHRS|MNMD (Mind Medicine (MindMed) Inc.) - Earnings per share increase in current year|Earnings per share growth in current year compasspathways.com CMPS|LB Corp (LBRX) - Earnings per share growth rate in current year|Bright Minds Biosciences - Earnings growth in current year|Cybin Inc (CYBN) - Net earnings per share growth this year|Alto Neuroscience (ANRO) - Earnings per share growth in current year|NRx Pharma - Earnings per share increase in current year|Earnings per share growth in current year Cingulate|Earnings per share growth in current year SILO|Earnings per share growth in current year China Pharma (CPHI)|Earnings growth in current year Clearmind Medicine, Inc. (CMND)|Earnings growth in current year PBM (Psyence Biomedical Ltd)|SPRC (SciSparc) - Earnings per share trend in current year|SEEL - Earnings per share growth in current year|VRPX (Virpax Pharmaceuticals Inc.) - Earnings per share growth this year|KRTX (Karuna Therapeutics) - Net earnings per share growth this year